Diabetes, Weight-Loss Drug Tied to Decreased Dementia Risk in T2D
TOPLINE: Semaglutide was associated with a 20%-46% reduced risk for Alzheimer’s disease (AD)-related dementia in patients with type 2 diabetes (T2D) compared with other antidiabetic medications, with a particularly strong protective effect against vascular dementia, new research showed. METHODOLOGY: Researchers examined electronic health records (EHRs) of more than 1.7 million US adults with T2D with […]
Diabetes, Weight-Loss Drug Tied to Decreased Dementia Risk in T2D Read More »
